A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2006
10/24/2006	US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
10/24/2006	US7125885 2-substituted-9-trifluoromethyl-11-methyl-1,2,3,4,5,11-hexahydro-6H-pyrido(3,2-b)carbazole compounds as melanin-concentrating hormone receptor modulators for treatment of G-protein coupled receptor-mediated disorders such as eating disorders, obesity, anxiety disorders and mood disorders
10/24/2006	US7125883 alpha v beta 3 integrin receptor modulators; treating variety of diseases including cardiovascular disorders, retinopathy, strokes, cancer, osteoporosis, tumor metastasis, high blood pressure, psoriasis, antiviral, antimycotic, antiparasitic or antibacterial therapy; 1,2-dihydropyrimidin-2-one moiety
10/24/2006	US7125878 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
10/24/2006	US7125877 Brain disorders; psychological disorders; central nervous system disorders; antidiabetic agents; hypotensive agents
10/24/2006	US7125873 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/24/2006	US7125864 Benzothiazepine derivatives for the treatment of hyperlipidemia
10/24/2006	US7125863 Inhibitors of dipeptidyl peptidase IV
10/24/2006	US7125839 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
10/24/2006	US7125708 Composition comprising a Lactobacillus pentosus strain and uses thereof
10/24/2006	US7125678 Protein biopolymer markers predictive of type II diabetes
10/24/2006	US7125547 Poly(diallylamine)-based bile acid sequestrants
10/24/2006	CA2273549C Diagnostic agents for pancreatic exocrine function
10/24/2006	CA2264598C 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridine derivatives
10/24/2006	CA2261848C Cell adhesion inhibitors
10/24/2006	CA2227711C Thioctic acid metabolites and methods of use thereof
10/24/2006	CA2205315C Fluorinated vitamin d3 analogs
10/20/2006	CA2603295A1 Use of ghrelin for the treatment of hyperthyroidism
10/19/2006	WO2006110483A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
10/19/2006	WO2006109867A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF
10/19/2006	WO2006109855A1 Peptide having food intake stimulating effect and method for screening for the peptide
10/19/2006	WO2006109846A1 Triazole derivative and the use thereof
10/19/2006	WO2006109633A1 Substituted indole compound
10/19/2006	WO2006108842A1 Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives as sglt inhibitors
10/19/2006	WO2006108283A1 Dietary fiber composition comprising glucomannan, xanthan gum, and alginate
10/19/2006	WO2006108208A1 A method for the treatment of gastrointestinal and other disorders with an admixture of vitamins and minerals
10/19/2006	WO2006076240A3 Compositions, products and methods for controlling weight in a mammal
10/19/2006	WO2006066937A3 Mnk1 or mnk2 inhibitors
10/19/2006	WO2006052135A3 Satiety enhancing compositions
10/19/2006	WO2006032042A3 Us of cntf or a cntf derivative in combination with a further compound for the preparation of medicament for the treatment of obesity
10/19/2006	WO2003027637A3 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
10/19/2006	US20060235078 Use of triterpenes of given formula based on a picene ring structure; side effect reduction such as of insulin resistance over current antidiabetes agents
10/19/2006	US20060235062 Novel heterocyclic analogs of diphenylethylene compounds
10/19/2006	US20060235058 Substituted 5-membered ring compounds and their use
10/19/2006	US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
10/19/2006	US20060235035 Novel methoxybenzamibe compounds for use in mch receptor related disorders
10/19/2006	US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same
10/19/2006	US20060235019 Substituted quinazolinone compounds
10/19/2006	US20060235015 Pyrrole-2,5-dione derivatives as liver x receptor modulators
10/19/2006	US20060235012 Carboline and betacarboline derivatives for use as hdac enzyme inhibitors
10/19/2006	US20060234991 Combinations for the treatment of immunoinflammatory disorders
10/19/2006	US20060234990 Compositions of boswellic acids derived from Boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
10/19/2006	US20060234957 Adiponectin expression promoter
10/19/2006	US20060234940 Secondary binding site of dipeptidyl peptidase IV (DP IV)
10/19/2006	US20060234932 Prolonged efficacy of islet neogenesis therapy methods with a gastrin/CCK receptor ligand and an EGF receptor ligand composition in subjects with preexisting diabetes
10/19/2006	US20060234930 Use of dg008,dg065,dg210 or dg239 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
10/19/2006	US20060234924 A kit for screening a compound or its salt that promotes or inhibits the activity of the proteins; drug screening for hyperlipemia, arteriosclerosis, genital, digestive, respiratory diseases, renal, pancreatic, central nerve, respiratory, inflammatory, rheumatoid diseases and diabetic neurosis
10/19/2006	US20060234913 Orally administering insulin and delivery agent 4-[(4-chloro, 2-hydroxybenzoyl)amino]butanoic acid that facilitates the absorption of insulin from the gastrointestinal tract; diabetes mellitus; bioavailability comparable to injection; treating diabetes without the drawbacks of systemic hyperglycemia
10/19/2006	US20060234307 Fusion proteins of of Fc domains with Ang-2 binding peptides; increases biological half life; angiopoietin-2 (Ang-2)
10/19/2006	US20060234276 Methods of treatment of type 2 diabetes
10/19/2006	US20060233902 Compositions and foods for improving lipid metabolism
10/19/2006	US20060233877 Betaine compositions
10/19/2006	US20060233861 Modulation of atp production or content in the hypothalamus
10/19/2006	US20060233804 IGF antagonist peptides
10/19/2006	US20060233746 N-terminally chemically modified protein compositions and methods
10/19/2006	DE102005017605A1 Substiuierte 2-Aminoalkylthio-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substiuierte 2-aminoalkylthio-benzimidazoles, process for their preparation and their use as medicaments
10/19/2006	DE102005016634A1 Neuartige Aza-Hetercyclen als Kinase-Inhibitoren Novel aza-heterocycles as kinase inhibitors
10/19/2006	CA2823646A1 Dietary supplement, and methods of use
10/19/2006	CA2778381A1 Dietary supplement, and methods of use
10/19/2006	CA2605377A1 Ghrelin binding nucleic acids
10/19/2006	CA2605245A1 Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives as sglt inhibitors
10/19/2006	CA2604773A1 Npy antagonists, preparation and use
10/19/2006	CA2603457A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
10/19/2006	CA2603402A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
10/19/2006	CA2583972A1 A method for the treatment of gastrointestinal and other disorders with an admixture of vitamins and minerals
10/18/2006	EP1712547A1 Bicycloester derivative
10/18/2006	EP1712232A1 Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
10/18/2006	EP1712225A1 Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists
10/18/2006	EP1711532A2 Combined use of a glp-1 agonist and gastrin compounds
10/18/2006	EP1711494A1 Aryl substituted heterocycles, method for production and use thereof as medicaments
10/18/2006	EP1711477A1 Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1
10/18/2006	EP1711473A1 Substituted n-cyclohexylimidazolinones having an mch-modulatory effect
10/18/2006	EP1711197A1 Methods and compositions for the prevention and treatment of inflammatory diseases or conditions
10/18/2006	EP1711184A1 (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
10/18/2006	EP1711180A1 Thiazolylimidazole derivatives and their use as inhibitors of microsomal triglyceride transfer protein
10/18/2006	EP1513418B1 Use of pullulan as a slowly digested carbohydrate
10/18/2006	EP1345932B1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
10/18/2006	EP1332206B1 Recombinant alpha-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
10/18/2006	EP1325749B1 Use of a bone metabolism improving agent
10/18/2006	EP1283828B1 Novel polymorph v of torasemide
10/18/2006	EP1208196B1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/18/2006	CN2827370Y 纤维素丸 Cellulose pill
10/18/2006	CN1849317A Crystal of heterocyclic compound
10/18/2006	CN1849309A Pyridyl derivatives and their use as therapeutic agents
10/18/2006	CN1849304A Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
10/18/2006	CN1849303A Novel heteroaryl derivative
10/18/2006	CN1847264A Insulin release promoter factor of rana grahami and its medicinal application
10/18/2006	CN1847258A A-decarbon-5 alpha-androstane-2-one-17 beta-alcohol ester and its prepn and use
10/18/2006	CN1847229A Novel compounds
10/18/2006	CN1847226A Quinolyl amide derivative and its prepn process and use
10/18/2006	CN1846765A Kidney benefiting hypoglycemic medicine composition and its prepn process
10/18/2006	CN1846758A Hypoglycemic medicine for treating diabetes and its prepn process
10/18/2006	CN1846757A Chinese medicine powder capsule for treating hypertension, hyperlipemia and cardiac and cerebral vascular diseases
10/18/2006	CN1846750A Groundcherry tincture and its prepn process
10/18/2006	CN1846737A Medicine for treating cardiac and cerebral vascular diseases and its prepn process
10/18/2006	CN1846735A Recipe of Chinese herbal medicine for lowering lipid and dissolving thrombus
10/18/2006	CN1846718A Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
10/18/2006	CN1846695A Application of 3,5,7,3',4',5'-hexahydroxyl-2,3-dihydroflavone in preparing medicine
10/18/2006	CN1846518A Plum food producing process
10/18/2006	CN1280409C Health protecting product composition with liver protecting and blood fat regulating function and its preparation

1 ... 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 ... 1298